首页> 外文期刊>Journal of the American Medical Directors Association >Potentially Inappropriate Prescribing for Prostatic Hyperplasia in Older Persons
【24h】

Potentially Inappropriate Prescribing for Prostatic Hyperplasia in Older Persons

机译:老年人前列腺增生的潜在不适当处方

获取原文
获取原文并翻译 | 示例
获取外文期刊封面目录资料

摘要

Objectives: In the context of improved medication management of older patients, we wished to evaluate the overprescription of potentially inappropriate drugs alpha 1-blockers and 5 alpha-reductase inhibitors (5-ARI) for benign prostate hyperplasia (BPH). These drugs are considered by geriatricians to increase the risk of falls and pharmacodynamic interactions, but these properties have not yet been proven. Design: This was a descriptive study of drug prescriptions in a geriatric academic center. Setting and Participants: We included all patients older than 75 years who received a prescription for alpha 1-blockers or 5-ARIs for 2 weeks in our hospital. Methods: We evaluated the prevalence of the potentially inappropriate prescription of alpha 1-blockers and 5-ARI in older people during hospitalization using a new tool consisting of an 8-item list of explicit indicators developed using the most recent summary of product characteristics (SmPC) and latest European Association of Urology (EAU) guidelines. Results: A population of 117 patients (>75 years) was included in the study. The median age was 84.5 (+/- 6.3) years. The average time since urological medication prescription was 1.2 +/- 1.6 years. According to explicit criteria, 84 patients (71.8) received at least 1 potentially inappropriate urologic medication, 77 (91.7) related to alpha 1-blockers. Patients with a potentially inappropriate prescription for alpha 1-blockers and/or 5-ARIs more frequently had urological assessments (P = .026), more frequently showed pharmacological interactions, with the risk of orthostatic hypotension (P = .005) or arrhythmia (P = .028), and experienced more falls in their history (P = .043). The misuse group was associated with an increased risk of falls, with an odds ratio of 3.22 (P = .039, 95 confidence interval 1.08-10.2). Conclusions and Implications: In our study, potentially inappropriate prescriptions for older individuals for BPH was close to 72 and mainly involved alpha 1-blockers. Potentially inappropriate prescriptions for BPH were associated with a threefold higher frequency of falls. (C) 2021 AMDA - The Society for Post-Acute and Long-Term Care Medicine.
机译:研究目的:在改善老年患者用药管理的背景下,我们希望评估潜在不适当药物[α 1-受体阻滞剂和5α-还原酶抑制剂(5-ARI)]对良性前列腺增生(BPH)的过度处方。老年病学家认为这些药物会增加跌倒和药效学相互作用的风险,但这些特性尚未得到证实。设计:这是一项对老年学术中心药物处方的描述性研究。环境和受试者:我们纳入了所有 75 岁以上的患者,这些患者在我们医院接受了 α1-受体阻滞剂或 5-ARI 的处方 2 周。方法:我们使用一种新工具评估了老年人住院期间潜在不适当的α-1-受体阻滞剂和5-ARI处方的患病率,该工具由使用最新的产品特征摘要(SmPC)和最新的欧洲泌尿外科协会(EAU)指南开发的8项明确指标列表组成。结果:本研究纳入117例患者(>75岁)。中位年龄为 84.5 (+/- 6.3) 岁。自泌尿科药物处方以来的平均时间为 1.2 +/- 1.6 年。根据明确的标准,84 例患者 (71.8%) 接受了至少 1 种可能不适当的泌尿系统药物,77 例 (91.7%) 与 α1 受体阻滞剂有关。α-1-受体阻滞剂和/或5-ARIs处方可能不合适的患者更频繁地进行泌尿科评估(P = .026),更频繁地显示药理学相互作用,具有直立性低血压(P = .005)或心律失常(P = .028)的风险,并且其病史中经历了更多的跌倒(P = .043)。误用组与跌倒风险增加相关,比值比为3.22(P=0.039,95%置信区间1.08-10.2)。结论和意义:在我们的研究中,老年人对 BPH 的潜在不适当处方接近 72%,主要涉及 α1 受体阻滞剂。潜在不适当的良性前列腺增生处方与跌倒频率高出三倍有关。(c) 2021 AMDA - 急性后和长期护理医学协会。

著录项

获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号